✦ LIBER ✦

Budget Impact Model of New Antiretroviral Biotechnology Medicines for Treatment of HIV/AIDS Patients in Bulgaria

✍ Scribed by Dimitrova, Maria; Petrova, Guenka; Cervenjakova, Tatiana; Jancheva, Nina; Stefanova, Mona; Manova, Manoela; Savova, Alexandra; Stoimenova, Assena

Book ID: 126569843
Publisher: Versita
Year: 2011
Tongue: English
Weight: 357 KB
Volume: 25
Category: Article
ISSN: 1310-2818
DOI: 10.5504/BBEQ.2011.0053

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN11 BUDGET IMPACT ANALYSIS OF NEW ANTR

PIN11 BUDGET IMPACT ANALYSIS OF NEW ANTRIRETROVIRAL MEDICINES FOR TREATMENT OF HIV PATIENTS IN BULGARIA

✍ MJ Dimitrova; MT Stefanova; GI Petrova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAM

PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAMIVUDINE FOR TREATMENT OF HIV INFECTED PATIENTS IN MEXICO

✍ K. Rely; G. Salinas Escudero; P.K. Alexandre 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Oral Lesions in HIV/AIDS Patients Underg

Oral Lesions in HIV/AIDS Patients Undergoing Highly Active Antiretroviral Treatment Including Protease Inhibitors: A New Face of Oral AIDS?

✍ Ceballos-Salobreña, Alejandro; Gaitán-Cepeda, Luis Alberto; Ceballos-Garcia, Lau 📂 Article 📅 2000 🏛 Mary Ann Liebert 🌐 English ⚖ 249 KB

PMS18 A BUDGET IMPACT MODEL FOR THE ECON

PMS18 A BUDGET IMPACT MODEL FOR THE ECONOMIC ASSESSMENT OF TOCILIZUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS IN ITALY

✍ S Iannazzo; O Zaniolo; G Giuliani 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Budget Impact of the Introduction of Elv

Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States

✍ Brogan, A.; Talbird, S.E.; Thompson, J.R.; Kim, Y.A.; Olson, J.; Peterson, J.; P 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

PAA3 A BUDGET IMPACT MODEL FOR DETERMINI

PAA3 A BUDGET IMPACT MODEL FOR DETERMINING THE COSTS OF INTRODUCING A NEW EXTRAFINE COMBINATION (BECLOMETHASONE/FORMOTEROL) FOR THE TREATMENT OF MODERATE TO SEVERE PERSISTENT ASTHMA IN SPAIN

✍ J Darba; G Restovic 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB